Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Usana Health Sciences (USNA) Return on Sales (2016 - 2025)

Historic Return on Sales for Usana Health Sciences (USNA) over the last 16 years, with Q3 2025 value amounting to 0.03%.

  • Usana Health Sciences' Return on Sales fell 800.0% to 0.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02%, marking a year-over-year decrease of 400.0%. This contributed to the annual value of 0.05% for FY2024, which is 200.0% down from last year.
  • Per Usana Health Sciences' latest filing, its Return on Sales stood at 0.03% for Q3 2025, which was down 800.0% from 0.04% recorded in Q2 2025.
  • In the past 5 years, Usana Health Sciences' Return on Sales ranged from a high of 0.11% in Q3 2021 and a low of 0.03% during Q3 2025
  • Its 5-year average for Return on Sales is 0.06%, with a median of 0.07% in 2022.
  • Examining YoY changes over the last 5 years, Usana Health Sciences' Return on Sales showed a top increase of 1300bps in 2022 and a maximum decrease of -1300bps in 2022.
  • Over the past 5 years, Usana Health Sciences' Return on Sales (Quarter) stood at 0.1% in 2021, then grew by 0bps to 0.1% in 2022, then decreased by -24bps to 0.08% in 2023, then crashed by -72bps to 0.02% in 2024, then crashed by -249bps to 0.03% in 2025.
  • Its Return on Sales stands at 0.03% for Q3 2025, versus 0.04% for Q2 2025 and 0.04% for Q1 2025.